NCT03782753View on ClinicalTrials.gov

Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

January 14, 2021

Study Completion Date

June 23, 2023

Conditions
Parkinson Disease, PARK8Parkinson DiseaseIdiopathic Parkinson Disease
Trial Locations (1)

Unknown

King's College London, London

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

King's College London

OTHER